|
ZNF37A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.353000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.169400E-01 |
| Normal-vs-Stage2 |
7.051600E-01 |
| Normal-vs-Stage3 |
7.819400E-03 |
| Normal-vs-Stage4 |
6.156400E-02 |
| Stage1-vs-Stage2 |
6.563200E-01 |
| Stage1-vs-Stage3 |
2.895800E-03 |
| Stage1-vs-Stage4 |
4.090300E-02 |
| Stage2-vs-Stage3 |
2.717400E-01 |
| Stage2-vs-Stage4 |
4.454400E-01 |
| Stage3-vs-Stage4 |
6.164200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.339800E-01 |
| Normal-vs-AfricanAmerican |
2.692300E-02 |
| Normal-vs-Asian |
7.882200E-01 |
| Caucasian-vs-AfricanAmerican |
1.114620E-01 |
| Caucasian-vs-Asian |
5.758600E-01 |
| AfricanAmerican-vs-Asian |
2.114000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.229800E-01 |
| Normal-vs-Female |
7.701400E-01 |
| Male-vs-Female |
1.876760E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.624780E-01 |
| Normal-vs-Age(41-60Yrs) |
9.773400E-01 |
| Normal-vs-Age(61-80Yrs) |
7.522100E-02 |
| Normal-vs-Age(81-100Yrs) |
1.402570E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.988600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.639600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.397800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.865800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.818170E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.796600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.641900E-02 |
| Normal-vs-Grade 2 |
5.564800E-01 |
| Normal-vs-Grade 3 |
2.859900E-02 |
| Normal-vs-Grade 4 |
5.881500E-03 |
| Grade 1-vs-Grade 2 |
2.452400E-01 |
| Grade 1-vs-Grade 3 |
9.498200E-03 |
| Grade 1-vs-Grade 4 |
3.103100E-03 |
| Grade 2-vs-Grade 3 |
2.841400E-03 |
| Grade 2-vs-Grade 4 |
8.553200E-04 |
| Grade 3-vs-Grade 4 |
2.446400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.090200E-02 |
| Normal-vs-ccB subtype |
3.464600E-03 |
| ccA subtype-vs-ccB subtype |
1.12350000003314E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.620800E-01 |
| Normal-vs-N1 |
3.815400E-01 |
| N0-vs-N1 |
6.972400E-01 |
|
|
